Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

11.96 +0.03 (+0.25%)
Streaming Delayed Price Updated: 9:41 AM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Orthofix Medical's Return on Invested Capital Insights ↗
According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $4.27 million, a 246.33% increase from the preceding quarter. Orthofix Medical also posted a total of $... 
Via Benzinga
News headline image
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical inc (OFIX) Q2 2021 Earnings Call Transcript ↗
OFIX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook ↗
Orthofix Medical Inc (NASDAQ: OFIX) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.59) a year ago, beating the consensus of $0.11. Sales... 
Via Benzinga
News headline image
Orthofix Medical: Q2 Earnings Insights ↗
Shares of Orthofix Medical (NASDAQ:OFIX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 154.24% over the past year to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Orthofix Reports Second Quarter 2021 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 6, 2021 ↗
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
News headline image
Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solution Containing Cancellous Bone
From Orthofix Medical Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces U.S. Launch and First Patient Implant of 3D-Printed FORZA Titanium PLIF Spacer System with Nanovate Technology
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Participation in Upcoming JMP Securities Life Sciences Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Participation in Upcoming Jefferies Virtual Healthcare Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Renews Sponsorship of Olympic Gold Medalist and Spine Patient Laura Wilkinson
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces US and European Full Market Launch of OSCAR PRO System for Removal of Cement During Complex Joint Revision Surgeries
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS
From Orthofix Medical Inc.
Via Business Wire
News headline image
MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc ↗
The FDA has given 510(k) clearance for Conformis Inc's (NASDAQ: CFMS) Identity Imprint Knee Replacement System, available in both cruciate-retaining (... 
Via Benzinga
News headline image
Orthofix Announces FDA Clearance of the OrthoNext Digital Platform for the JuniOrtho Plating System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Medical Inc (OFIX) Q1 2021 Earnings Call Transcript ↗
OFIX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Orthofix Reports First Quarter 2021 Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Exclusive US License for IGEA’s Bone and Joint Stimulation Devices
From Orthofix Medical Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Orthofix Schedules First Quarter Earnings Release and Conference Call for April 30, 2021
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces FDA Clearance and First Patient Implant of the 3D-Printed FORZA Titanium TLIF Spacer System with Nanovate Technology
From Orthofix Medical Inc.
Via Business Wire
News headline image
Earnings Scheduled For April 30, 2021 ↗
Companies Reporting Before The Bell • O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million. • Twin... 
Via Benzinga
News headline image
Orthofix Announces Board Chair Transition
From Orthofix Medical Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.